Conversely, it has been recently reported that in pancreatic adenocarcinoma, IL-33 induces ILC2 expansion that was accompanied by enhanced intratumoral CD8+ T cells pushing tissue-specific tumor immunity (Moral et al., 2020). This evidence concerns the gene CD8A and neoplasm.